Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: A novel therapy for treatment of diabetic complications

Archives of Biochemistry and Biophysics

Volumn 419, Issue 1, 2003, Pages 41-49

  Metz, Thomas O ^a   Alderson, Nathan L ^a   Thorpe, Suzanne R ^a   Baynes, John W ^a,b  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced glycation end product; Advanced lipoxidation end product; Diabetic nephropathy; Hyperlipidemia; Maillard reaction

Indexed keywords

2 ISOPROPYLIDENEHYDRAZONO 4 OXO 5 THIAZOLIDINYLACETANILIDE; ADVANCED GLYCATION END PRODUCT; ALT 946; AMINOGUANIDINE; ANTILIPEMIC AGENT; DIAMINOPHENAZINE; LIPID; PYRIDOXAMINE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; CHEMICAL REACTION; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC OBESITY; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; GLYCATION; HUMAN; HYPERLIPIDEMIA; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; STREPTOZOCIN DIABETES; URINALYSIS;

ANIMALIA;

EID: 0142058743     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.abb.2003.08.021     Document Type: Review

References (48)

1. Baynes J.W., Thorpe S.R. Glycation and advanced glycation reactions. Turtle J.R., Kaneko T., Osato S. Diabetes in the New Millennium. 1999;337-350 Endocrinology and Diabetes Research Foundation, Sydney.
2. Ulrich P., Cerami A. Recent Prog. Horm. Res. 56:2001;1-21.
3. Hamada Y., Araki N., Koh N., Nakamura J., Horiuchi S., Hotta N. Biochem. Biophys. Res. Commun. 228:1996;539-543.
4. Fu M.-X., Requena J.R., Jenkins A.J., Lyons T.J., Baynes J.W., Thorpe S.R. J. Biol. Chem. 271:1996;9982-9986.
5. Onorato J.M., Jenkins A.J., Thorpe S.R., Baynes J.W. J. Biol. Chem. 275:2000;21177-21184.
6. Anderson M.M., Requena J.R., Crowley J.R., Thorpe S.R., Heinecke J.W. J. Clin. Invest. 104:1999;103-113.
7. Fu S., Fu M.X., Baynes J.W., Thorpe S.R., Dean R.T. Biochem. J. 330(Pt 1):1998;233-239.
8. Sakata N., Imanaga Y., Meng J., Tachikawa Y., Takebayashi S., Nagai R., Horiuchi S., Itabe H., Takano T. Atherosclerosis. 141:1998;61-75.
9. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., Heinecke J.W. J. Biol. Chem. 272:1997;3520-3526.
10. Thorpe S.R., Baynes J.W. Drugs Aging. 9:1996;69-77.
11. Beal M.F. Free Radic. Biol. Med. 32:2002;797-803.
12. Miyata T., Sugiyama S., Saito A., Kurokawa K. Kidney Int. 59(Suppl. 78):2001;S25-S31.
13. Sebekova K., Kupcova V., Schinzel R., Heidland A. J. Hepatol. 36:2002;66-71.
14. Yim M.B., Yim H.S., Lee C., Kang S.O., Chock P.B. Ann. NY Acad. Sci. 928:2001;48-53.
15. Saxena P., Saxena A.K., Cui X.L., Obrenovich M., Gudipaty K., Monnier V.M. Invest. Ophthalmol. Vis. Sci. 41:2000;1473-1481.
16. Qian M., Liu M., Eaton J.W. Biochem. Biophys. Res. Commun. 250:1998;385-389.
17. Nilsson B.O. Inflamm. Res. 48:1999;509-515.
18. Hirsch J., Baynes J.W., Blackledge J.A., Feather M.S. Carbohydrate Res. 220:1991;c5-c7.
19. Miyata T., van Ypersele de Strihou C., Ueda Y., Ichimori K., Inagi R., Onogi H., Ishikawa N., Nangaku M., Kurokawa K. J. Am. Soc. Nephrol. 13:2002;2478-2487.
20. Degenhardt T.P., Alderson N.L., Arrington D.D., Beattie R.J., Basgen J.M., Steffes M.W., Thorpe S.R., Baynes J.W. Kidney Int. 61:2002;939-950.
21. Abdel-Rahman E., Bolton W.K. Expert Opin. Invest. Drugs. 11:2002;565-574.
22. Philis-Tsimikas A., Parthasarathy S., Picard S., Palinski W., Witztum J.L. Arteriosc. Thromb. Vasc. Biol. 15:1995;367-376.
23. Price D.L., Rhett P.M., Thorpe S.R., Baynes J.W. J. Biol. Chem. 276:2001;48967-48972.
24. Southan G.J., Szabo C. Biochem. Pharmacol. 51:1996;383-394.
25. Booth A.A., Khalifah R.G., Hudson B.G. Biochem. Biophys. Res. Commun. 220:1996;113-119.
26. Booth A.A., Khalifah R.G., Todd P., Hudson B.G. J. Biol. Chem. 272:1997;5430-5437.
27. Khalifah R.G., Todd P., Booth A.A., Yang S.X., Mott J.D., Hudson B.G. Biochemistry. 35:1996;4645-4654.
28. Khalifah R.G., Baynes J.W., Hudson B.G. Biochem. Biophys. Res. Commun. 257:1999;251-258.
29. Nagaraj R.H., Sarkar P., Mally A., Biemel K.M., Lederer M.O., Padayatti P.S. Arch. Biochem. Biophys. 402:2002;110-119.
30. Stitt A., Gardiner T.A., Alderson N.L., Canning P., Frizzell N., Duffy N., Boyle C., Januszewski A.S., Chachich M., Baynes J.W., Thorpe S.R. Diabetes. 51:2002;2826-2832.
31. J.W. Baynes, Glycation and advanced glycation reactions, in: F.A. Gries, N.E. Cameron, P.A. Low, D. Ziegler (Eds.), Diabetic Neuropathy. Thieme Medical Publishers, Stuttgart, 2003, in press.
32. Alderson N.A., Chachich M.E., Youssef N.N., Nachtigal M., Beattie R.J., Thorpe S.R., Baynes J.W. Kidney Int. 63:2003;2123-2133.
33. Attman P.-O., Alaupovic P., Samuelsson O. Kidney Int. 56(Suppl. 71):1999;S14-S17.
34. Keane W.F. Kidney Int. 57(Suppl. 75):2000;S27-S31.
35. Sasatomi Y., Tada M., Uesugi N., Hisano S., Takebayashi S. Pathobiology. 69:2001;113-118.
36. Maddox D.A., Alavi F.K., Santella R.N., Zawada E.T. Jr. Kidney Int. 62:2002;208-219.
37. Alderson N.L., Metz T.O., Chachich M.E., Baynes J.W., Thorpe S.R. Diabetes. 50(Suppl. 2):2001;A172.
38. Glomb M.A., Pfahler C. J. Biol. Chem. 276:2002;41638-41647.
39. Voziyan P.A., Metz T.O., Baynes J.W., Hudson B.G. J. Biol. Chem. 277:2002;3397-3403.
40. Loidl-Stahlhofen A., Spiteller G. Biochim. Biophys. Acta. 1211:1994;156-160.
41. Schmidt A.M., Yan S.D., Wautier J.L., Stern D. Circ. Res. 84:1999;489-497.
42. Yang S.Z., Litchfield J.E., Baynes J.W. Arch. Biochem. Biophys. 412:2003;42-46.
43. Hasenkopf K., Ronner B., Hiller H., Pischetsrieder M. J. Agric. Food Chem. 50:2002;5697-5703.
44. Jain S.K., Lim G. Free Radic. Biol. Med. 30:2001;232-237.
45. Shimoi K., Okitsu A., Green M.H., Lowe J.E., Ohta T., Kaji K., Terato H., Ide H., Kinae N. Mutat. Res. 480-481:2001;371-378.
46. Suzuki D., Miyata T., Kurokawa K. Contrib. Nephrol. 134:2001;36-45.
47. Guijarro C., Keane W.F. Curr. Opin. Nephrol. Hypertens. 2:1993;372-379.
48. Saito T. Tohoku J. Exp. Med. 181:1997;321-337.